Ainos, Inc. (NASDAQ:AIMD – Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 634,100 shares, an increase of 258.0% from the December 31st total of 177,100 shares. Approximately 14.5% of the shares of the company are short sold. Based on an average trading volume of 621,400 shares, the days-to-cover ratio is currently 1.0 days.
Ainos Trading Down 3.9 %
AIMD opened at $0.68 on Friday. The firm has a 50-day moving average price of $0.54 and a 200-day moving average price of $0.56. Ainos has a twelve month low of $0.40 and a twelve month high of $3.10. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50.
Ainos (NASDAQ:AIMD – Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported ($0.33) earnings per share (EPS) for the quarter.
About Ainos
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Featured Stories
- Five stocks we like better than Ainos
- How to Find Undervalued Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is a support level?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.